Kuter, D., Yunfei, C., Cooper, N., Ghanima, W., Kato, H., Tomiyama, Y., Wong, R., Yang, R., Li, C., Skelton, E., Wang, S., Yee, D., Patwari, P. (2025). Trial in progress: Study design of a randomized, phase 3 trial evaluating the efficacy and safety of mezagitamab (TAK-079) compared with placebo in adults with chronic primary immune thrombocytopenia. Blood. https://doi.org/10.1182/blood-2025-3049